Quarterly Result11 Feb 2026, 02:22 pm
Emmessar Biotech & Nutrition Ltd. Reports Q3 Results for 2025
AI Summary
Emmessar Biotech & Nutrition Ltd. has reported its unaudited financial results for the quarter ended 31st December 2025. The results have been reviewed by the Audit Committee and approved by the Board of Directors. The company operates two segments: Healthcare and Rent on Leasehold Land. No investors' complaints were received during the quarter. The results are in compliance with the Indian Accounting Standards and the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company will continue to monitor the impact of the recently notified Labour Codes.
Key Highlights
- Unaudited financial results for Q3 2025 reported.
- Reviewed by the Audit Committee and approved by the Board of Directors.
- Company operates two segments: Healthcare and Rent on Leasehold Land.
- No investors' complaints received during the quarter.
- Results are in compliance with Indian Accounting Standards and SEBI regulations.
Price Impact
More from EMMESSA